185 related articles for article (PubMed ID: 26919249)
1. Elevated expression of HIF-lα in actively growing prostate tissues is associated with clinical features of benign prostatic hyperplasia.
Wu F; Ding S; Li X; Wang H; Liu S; Wu H; Bi D; Ding K; Lu J
Oncotarget; 2016 Mar; 7(11):12053-62. PubMed ID: 26919249
[TBL] [Abstract][Full Text] [Related]
2. Expression of hypoxia-inducible factor 1alpha in human normal, benign, and malignant prostate tissue.
Du Z; Fujiyama C; Chen Y; Masaki Z
Chin Med J (Engl); 2003 Dec; 116(12):1936-9. PubMed ID: 14687488
[TBL] [Abstract][Full Text] [Related]
3. Vitamin C supplementation prevents testosterone-induced hyperplasia of rat prostate by down-regulating HIF-1alpha.
Li SH; Ryu JH; Park SE; Cho YS; Park JW; Lee WJ; Chun YS
J Nutr Biochem; 2010 Sep; 21(9):801-8. PubMed ID: 19716283
[TBL] [Abstract][Full Text] [Related]
4. The expression of hypoxia-inducible factor-1alpha (HIF-1alpha) and angiogenesis markers in hyperplastic and malignant prostate tissue.
Lekas A; Lazaris AC; Deliveliotis C; Chrisofos M; Zoubouli C; Lapas D; Papathomas T; Fokitis I; Nakopoulou L
Anticancer Res; 2006; 26(4B):2989-93. PubMed ID: 16886625
[TBL] [Abstract][Full Text] [Related]
5. [Expression of hypoxia-inducible factor 1 alpha and vascular endothelial growth factor in prostate cancer and its significance].
Wang L; Chen ZJ; Wang QT; Cao WF; Jian Y; Wang SX; Zhang BH
Zhonghua Nan Ke Xue; 2006 Jan; 12(1):57-9. PubMed ID: 16483162
[TBL] [Abstract][Full Text] [Related]
6. Pathogenic role of HIF-1α in prostate hyperplasia in the presence of chronic inflammation.
Kim HJ; Park JW; Cho YS; Cho CH; Kim JS; Shin HW; Chung DH; Kim SJ; Chun YS
Biochim Biophys Acta; 2013 Jan; 1832(1):183-94. PubMed ID: 22986049
[TBL] [Abstract][Full Text] [Related]
7. [Histological changes of the prostate and acute urinary retention in patients with benign prostatic hyperplasia].
Bao QB; He GH; Liu GY; Zhang CG; Yang C
Zhonghua Nan Ke Xue; 2013 Sep; 19(9):811-4. PubMed ID: 24386860
[TBL] [Abstract][Full Text] [Related]
8. Relationship between the prostatic tissue components and natural history of benign prostatic hyperplasia.
Matsuda T; Fujime M; Suda K
Anal Quant Cytol Histol; 2006 Jun; 28(3):121-4. PubMed ID: 16786720
[TBL] [Abstract][Full Text] [Related]
9. Finasteride effects on hypoxia and angiogenetic markers in benign prostatic hyperplasia.
Lekas AG; Lazaris AC; Chrisofos M; Papatsoris AG; Lappas D; Patsouris E; Deliveliotis C
Urology; 2006 Aug; 68(2):436-41. PubMed ID: 16904480
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms in key hypoxia-regulated downstream molecules and phenotypic correlation in prostate cancer.
Fraga A; Ribeiro R; Coelho A; Vizcaíno JR; Coutinho H; Lopes JM; Príncipe P; Lobato C; Lopes C; Medeiros R
BMC Urol; 2017 Jan; 17(1):12. PubMed ID: 28143503
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress promotes benign prostatic hyperplasia.
Vital P; Castro P; Ittmann M
Prostate; 2016 Jan; 76(1):58-67. PubMed ID: 26417670
[TBL] [Abstract][Full Text] [Related]
12. The effects of ROS in prostatic stromal cells under hypoxic environment.
Ren H; Li X; Cheng G; Li N; Hou Z; Suo J; Wang J; Za X
Aging Male; 2015 Jun; 18(2):84-8. PubMed ID: 25746207
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of NKX3.1 in benign prostatic hyperplasia.
Irer B; Toylu A; Aslan G; Celebi I; Yorukoglu K; Atabey N
Urology; 2009 May; 73(5):1140-4. PubMed ID: 18597829
[TBL] [Abstract][Full Text] [Related]
14. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
[TBL] [Abstract][Full Text] [Related]
15. Increased growth factor production in a human prostatic stromal cell culture model caused by hypoxia.
Berger AP; Kofler K; Bektic J; Rogatsch H; Steiner H; Bartsch G; Klocker H
Prostate; 2003 Sep; 57(1):57-65. PubMed ID: 12886524
[TBL] [Abstract][Full Text] [Related]
16. [Experimental study on the penetrability of trypan blue to the rat prostate].
Wang H; Chen Z; Zhu Y
Zhonghua Nan Ke Xue; 2004 Nov; 10(11):811-4. PubMed ID: 15595679
[TBL] [Abstract][Full Text] [Related]
17. Clinical progression, acute urinary retention, prostate-related surgeries, and costs in patients with benign prostatic hyperplasia taking early versus delayed combination 5α-reductase inhibitor therapy and α-blocker therapy: a retrospective analysis.
Morlock R; Goodwin B; Gomez Rey G; Eaddy M
Clin Ther; 2013 May; 35(5):624-33. PubMed ID: 23583026
[TBL] [Abstract][Full Text] [Related]
18. Increased and localized accumulation of chondroitin sulphate proteoglycans in the hyperplastic human prostate.
Cardoso LE; Falcão PG; Sampaio FJ
BJU Int; 2004 Mar; 93(4):532-8. PubMed ID: 15008724
[TBL] [Abstract][Full Text] [Related]
19. [Expression and its significance of b-FGF in human benign prostatic hyperplasia and prostatic carcinoma tissues].
Wang FL; Wang H; Qin WJ; Wu GJ; Zhang G; Li KN
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Mar; 20(2):203-5. PubMed ID: 15191726
[TBL] [Abstract][Full Text] [Related]
20. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
